References
- Frassoni F., Labopin M., Gluckman E., Prentice H. G., Gahrton G., Mandelli F., Carella M., Herve P., Gratwohl A., Goldman J. and Gorin N. C. (1994) On behalf of the Acute Leukemia Working Party of the European Group for Bone Marrow Transplantation (EBMT). Are Patients With Acute Leukemia, Alive and Well 2 Years Post Bone Marrow Transplantation Cured? A European Survey. Leukemia, Vol 8, No 6, 924–928.
- Gassmann W., Schmitz N., Loffler H. and De Witte T. (1996) Intensive Chemotherapy and Bone Marrow Transplantation for Myelodysplastic Syndromes. Seminars in Hematology, Vol 33, No 3, 196–205.
- De Witte T., Hermans J., Van Biezen J., Vemant J., Kolb H., Zwaan F., Vossen J., Lonnqvist B., Beelen D., Ferrant A., Gmur J., Liu Yin J., Troussard X., Cahn J., Van Lint M., Gratwohl A. and Verdonk L. (1991) Prognostic Variables in Bone Marrow Transplantation for Secondary Leukemia and Myelodysplastic Syndromes: A Survey of the Working Party on Leukemia. Bone Marrow Transplantation, (8)Suppl. 1, 40–41.
- De Witte T., Zwaan F., Hermans J., Vernant J., Kolb H., Vossen J., Lonnqvist B., Beelen D., Ferrant A., Gmur J., Liu Yin J., Troussard X., Cahn J., Van Lint M. and Gratwohl A. (1990) Allogeneic Bone Marrow Transplantation for Secondary leukemia and Myelodysplastic syndrome: A Survey by the Leukemia Working Party of the European Bone Marrow Transplantation Group. Br J Haematology, 74, 151–155.
- Anderson J. E., Appelbaum F. R., Fisher L. D., Schoch G., Shulman H., Anasetti C., Bensinger W. I., Bryant E., Buckner C. D., Doney K., Martin P. J., Sanders J. E., Sullivan K. M., Thomas E. D., Witherspon R. P., Hansen J. A. and Storb R. (1993) Allogeneic Bone Marrow Transplantation for 93 Patients with Myelodysplastic Syndrome. Blood, Vol 82, 2, 677–681.
- Kolb H. J., Schattenberg A., Goldman J. M., Hertenstein B., Jacobsen N., Arcese W., Ljungman P., Ferrant A., Verdonck L., Niederwieser D., Van Rhee F., Mittermueler J., De Witte T., Holler E. and Ansari H. (1995) Graft Versus Leukemia Effect of Donor Leukocyte Transfusions in Marrow Grafted Patients. Blood, Vol 86, 5, 2041–2050.